<DOC>
	<DOC>NCT02268279</DOC>
	<brief_summary>Pediatric study to evaluate the safety and pharmacokinetics of solithromycin (oral and intravenous) in children ages 0 to 17</brief_summary>
	<brief_title>Pharmacokinetics and Safety of Solithromycin in Adolescents and Children</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<criteria>Suspected or confirmed bacterial infection with organisms against which solithromycin is expected to be active. Serum creatinine &gt;2 mg/dL Positive pregnancy test in females of childbearing potential History of intolerance or hypersensitivity to macrolide antibiotics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>